LABT · Company research

Lakewood-Amedex Biotherapeutics Inc. (LABT): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

18records availableHealthcare

Stock News & Events data

Database-backed records only

18 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
LABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXCLABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC MEXCView source ↗MEXCOct 15, 2026neutral00.6
A compound inhibited up to 97% of E. coli growth in rodents; the control group showed no effect. - Stock TitanA compound inhibited up to 97% of E. coli growth in rodents; the control group showed no effect. Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
LABT Stock Slides As Volatility Spikes On Heavy Trading - StocksToTradeLABT Stock Slides As Volatility Spikes On Heavy Trading StocksToTradeView source ↗StocksToTradeSep 28, 2026neutral00.6
LABT Stock Whipsaws As Traders Focus On Cash And Volatility - Timothy SykesLABT Stock Whipsaws As Traders Focus On Cash And Volatility Timothy SykesView source ↗Timothy SykesSep 28, 2026neutral00.6
Is Lakewood-Amedex Biotherapeutics Inc. (LABT) Rewriting the Penny Stocks Playbook? - Kalkine MediaIs Lakewood-Amedex Biotherapeutics Inc. (LABT) Rewriting the Penny Stocks Playbook? Kalkine MediaView source ↗Kalkine MediaSep 25, 2026neutral00.6
Lakewood-Amedex Biotherapeutics Inc. SEC Filing (Sep 25, 2026) - Stock TitanLakewood-Amedex Biotherapeutics Inc. SEC Filing (Sep 25, 2026) Stock TitanView source ↗Stock TitanSep 25, 2026neutral00.6
Lakewood-Amedex Biotherapeutics (LABT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeatLakewood-Amedex Biotherapeutics (LABT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 MarketBeatView source ↗MarketBeatSep 24, 2026neutral00.6
The first patient has received a germ-fighting gel being tested for infected diabetic foot ulcers. - Stock TitanThe first patient has received a germ-fighting gel being tested for infected diabetic foot ulcers. Stock TitanView source ↗Stock TitanSep 24, 2026neutral00.6
Before human trials, a wound gel killed drug-resistant bacteria without generating resistance - Stock TitanBefore human trials, a wound gel killed drug-resistant bacteria without generating resistance Stock TitanView source ↗Stock TitanSep 21, 2026neutral00.6
LABT: Advancing Toward Phase 2a Study of Nu-3 in Infected Diabetic Foot Ulcers - Zacks Investment ResearchLABT: Advancing Toward Phase 2a Study of Nu-3 in Infected Diabetic Foot Ulcers Zacks Investment ResearchView source ↗Zacks Investment ResearchAug 26, 2026neutral00.6
Market Movers | Winners: LABT, ADVB, KUST | Losers: CPHI, SGRP, ATER - TrefisMarket Movers | Winners: LABT, ADVB, KUST | Losers: CPHI, SGRP, ATER TrefisView source ↗TrefisJul 23, 2026neutral00.6
Lakewood-Amedex Biotherapeutics Surges as Fresh Nu-3 Data Draws Attention to Its Antibiotic-Resistance Program - Quiver QuantitativeLakewood-Amedex Biotherapeutics Surges as Fresh Nu-3 Data Draws Attention to Its Antibiotic-Resistance Program Quiver QuantitativeView source ↗Quiver QuantitativeJul 22, 2026neutral00.6
LABT Stock Whipsaws As Traders Eye Virtual Forum Exposure - timothysykes.comLABT Stock Whipsaws As Traders Eye Virtual Forum Exposure timothysykes.comView source ↗timothysykes.comJul 22, 2026neutral00.6
LABT Stock Whipsaws As Traders React To Conference Spotlight - StocksToTradeLABT Stock Whipsaws As Traders React To Conference Spotlight StocksToTradeView source ↗StocksToTradeJul 22, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNApr 24, 2026neutral00.6
Lakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Forum & Discussion - Yahoo! Finance CanadaLakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Forum & Discussion Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaApr 7, 2026neutral00.6
Lakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Price, News, Quote & History - Yahoo! Finance CanadaLakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaMar 4, 2026neutral00.6
Lakewood-Amedex Biotherapeutics, Inc. (LABT) stock price, news, quote and history - Yahoo Finance UKLakewood-Amedex Biotherapeutics, Inc. (LABT) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKDec 29, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.